These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18761385)

  • 1. Up-regulation of kinesin light-chain 1 gene expression by acetyl-L-carnitine: therapeutic possibility in Alzheimer's disease.
    Traina G; Federighi G; Brunelli M
    Neurochem Int; 2008 Dec; 53(6-8):244-7. PubMed ID: 18761385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially expressed genes induced in the rat brain by acetyl-L-carnitine as evidenced by suppression subtractive hybridisation.
    Traina G; Valleggi S; Bernardi R; Rizzo M; Calvani M; Nicolai R; Mosconi L; Durante M; Brunelli M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):57-63. PubMed ID: 15548429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-L-carnitine up-regulates expression of voltage-dependent anion channel in the rat brain.
    Traina G; Bernardi R; Rizzo M; Calvani M; Durante M; Brunelli M
    Neurochem Int; 2006 Jun; 48(8):673-8. PubMed ID: 16527372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
    Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
    Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.
    Tolón RM; Núñez E; Pazos MR; Benito C; Castillo AI; Martínez-Orgado JA; Romero J
    Brain Res; 2009 Aug; 1283():148-54. PubMed ID: 19505450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of amyloid plaque pathogenesis.
    Fiala JC
    Acta Neuropathol; 2007 Dec; 114(6):551-71. PubMed ID: 17805553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2.
    Nagai K; Takikawa O; Kawakami N; Fukao M; Soma T; Oda A; Nishiya T; Hayashi M; Lu L; Nakano M; Kajita E; Fujita H; Miwa S
    Arch Biochem Biophys; 2006 Aug; 452(1):29-37. PubMed ID: 16839516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decorated plaques in Alzheimer's disease.
    Tabira T
    Ann Neurol; 2009 Jan; 65(1):4-6. PubMed ID: 19194874
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
    Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
    Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden.
    Kellner A; Matschke J; Bernreuther C; Moch H; Ferrer I; Glatzel M
    Ann Neurol; 2009 Jan; 65(1):24-31. PubMed ID: 19194878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease.
    Kalaria RN; Harik SI
    Ann Neurol; 1992 Oct; 32(4):583-6. PubMed ID: 1456745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-L-carnitine.
    Altern Med Rev; 1999 Dec; 4(6):438-41. PubMed ID: 10608918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons.
    Epis R; Marcello E; Gardoni F; Longhi A; Calvani M; Iannuccelli M; Cattabeni F; Canonico PL; Di Luca M
    Eur J Pharmacol; 2008 Nov; 597(1-3):51-6. PubMed ID: 18801359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease.
    Tsai KJ; Yang CH; Lee PC; Wang WT; Chiu MJ; Shen CK
    Neuroscience; 2009 Mar; 159(2):638-46. PubMed ID: 19167467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-L-carnitine affects nonassociative learning processes in the leech Hirudo medicinalis.
    Ristori C; Cataldo E; Zaccardi ML; Traina G; Calvani M; Lombardo P; Scuri R; Brunelli M
    Neuroscience; 2006 Nov; 142(4):931-9. PubMed ID: 16916587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiological functions of carnitine and carnitine transporters in the central nervous system].
    Inazu M; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):113-20. PubMed ID: 18646596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.